A US-based clinical-stage neurobehavioral health company partnered with NewPage to develop a groundbreaking machine learning platform. This innovative solution aims to revolutionize personalized healthcare by bridging the gap between complex neuroimaging data and behavioral patterns.
Challenge
The primary challenge was deciphering intricate neuroimaging maps and translating them into actionable insights for effective treatments. NewPage’s mission was to create a platform capable of decoding neural complexities and correlating them with latent behavioral features, a crucial step towards delivering personalized care.
Approach
Leveraging our expertise in advanced analytics and predictive modeling in healthcare, NewPage developed a versatile platform that:
- Operates with various neuroimaging inputs
- Utilizes APIs for data gathering, preparation, initialization, and projection
- Harnesses customer data, cloud technology, and AI
Results
NewPage’s solution represents a paradigm shift in neurobehavioral treatment methodologies. The platform empowers our client with:
- Access to scalable and robust analytics functions
- Deep insights driving informed decision-making
- Opportunities for strategic partnerships
With this innovative platform, our client is poised to transform neurobehavioral healthcare, paving the way for truly personalized treatments tailored to each patient’s unique needs.
More case studies
Qiyas Genomics Delivers Patient-Ready Genomic Reports in 5 Minutes Using AWS
A genetic diagnosis is one of the few places in medicine where the answer exists in the data from the very beginning. Sequencing a patient's genome produces that answer. However, the operational distance between the sequencer and the clinician—aligning reads, calling variants, filtering millions of differences, and formatting a report—has historically bottlenecked clinical diagnostics. Working with AWS Select Tier Consulting Partner NewPage Solutions, Qiyas Genomics built a unified clinical platform on Amazon Web Services (AWS) to compress that distance. By automating the pipeline from raw sequencing data to clinical interpretation, Qiyas Genomics reduced the time it takes to generate a customized, patient-ready diagnostic report to approximately five minutes.
Top-5 Global Pharmaceutical Company Accelerates Drug Label Change Impact Analysis by 90% Using Amazon Bedrock
When a regulatory body approves a change to a medicine's label, a strict 90-day compliance clock begins. Every piece of active promotional content referencing that medicine must be located, reviewed, and updated to reflect the approved language. For a top-5 global pharmaceutical company, managing this process manually consumed nearly half of their compliance window. Working with AWS Select Tier Consulting Partner NewPage Solutions, the company deployed a specialized, nine-agent AI pipeline powered by Amazon Web Services (AWS). By automating document comparison and asset mapping with Amazon Bedrock, the company reduced asset identification time from up to 40 days to just four days, transforming its regulatory risk posture and extending its AI development roadmap through 2027.
Scalable Cost Control and Team Analytics Powered by Retool
Ops leads struggled with fragmented license tracking, invisible costs, and zero team activity insights. Newpage designed Retool-powered cost command centre that helped with license cost consolidation, proactive budgeting and resource planning.